Evan Leitner has represented high growth companies and investment banks on capital markets and corporate transactions, including initial and follow-on public equity offerings and high-yield, investment-grade and convertible debt offerings. Evan also counsels publicly held companies with respect to corporate governance, SEC reporting and securities law compliance.

Download full bio 

Experience

  • Warby Parker – Direct Listing 

  • Elevation Oncology – $107 Million IPO 

  • GH Research – $184 Million IPO 

  • SPAC BowX Agrees to $9 Billion Merger With WeWork 

  • ACV Auctions – $476 Million IPO 

  • View all

Education

  • New York University School of Law
    JD, 2015

  • Yale University
    BA, 2009


Admissions & Credentials

New York

New Jersey

Massachusetts